Extended Management and Measurement of Autism

PHASE3TerminatedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Autistic Disorder
Interventions
DRUG

Fluoxetine (prozac)

Formulation: ODT

Trial Locations (13)

10029

Mount Sinai School of Medicine, New York

11714

Long Island Jewish Hospital, Bethpage

27514

University of North Carolina, Chapel Hill

30080

Institute for Behavioral Medicine, Smyrna

43210

Ohio State University, Columbus

48201

Children's Hospital of Michigan, Detroit

60563

AMR-Baber Research Inc., Naperville

85006

Southwest Autism Research and Resource Centre, Phoenix

95817

University of California Davis, Sacramento

60637-1448

University of Illinois, Chicago

02155

Harvard Medical School, Medford

08043

CRCNJ, Voorhees Township

98105-0371

Seattle Children's Hosptial University of Washington, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Autism Speaks

OTHER

lead

Neuropharm

INDUSTRY